1 |
Balkwill F (2004). Cancer and the chemokine network. Nat Rev Cancer, 4, 540-50.
DOI
ScienceOn
|
2 |
Cai C, Rodepeter FR, Rossmann A, et al (2012). SIVmac239-Nef down-regulates cell surface expression of CXCR4 in tumor cells and inhibits proliferation, migration and angiogenesis. Anticancer Res, 32, 2759-68.
|
3 |
Heinrich EL, Lee W, Lu J, Lowy AM, Kim J (2012). Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells. J Transl Med, 10, 68.
DOI
|
4 |
Huang Y, Zhang J, Cui ZM, Zhao J, Zheng Y (2013). Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer. Chin J Cancer, 32, 289-96.
DOI
|
5 |
Kodama J, Hasengaowa, Kusumoto T, et al (2007). Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer. Ann Oncol, 18, 70-6.
|
6 |
Ma D, Ling X (2001). Advances in the epidemiology and etiology of cervical cancer. J Practical Obstet Gynecol, 17, 61-3.
|
7 |
Miao Z, Luker KE, Summers BC, et al (2007). CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA, 4, 5735-40.
|
8 |
Paradkar PH, Joshi JV, Mertia PN, Agashe SV, Vaidya RA (2014). Role of cytokines in genesis, progression and prognosis of cervical cancer. Asian Pac J Cancer Prev, 15, 3851-64.
과학기술학회마을
DOI
|
9 |
Roy I, Zimmerman NP, Mackinnon AC, et al (2014). CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. Plops One, 9, 90400.
DOI
|
10 |
Schrevel M, Karim R, Ter Haar NT, et al (2012). CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients. Br J Cancer, 106, 1520-5.
DOI
|
11 |
Shen B, Zheng MQ, Lu JW, et al (2013). CXCL12-CXCR4 promotes proliferation and invasion of pancreatic cancer cells. Asian Pac J Cancer Prev, 14, 5403-8.
과학기술학회마을
DOI
ScienceOn
|
12 |
Sun X, Cheng G, Hao M, Zheng J, et al (2010). CXCL12/ CXCR4/ CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev, 29, 709-22.
DOI
ScienceOn
|
13 |
Suzuk L, Peng YH, Zhou FS (2006). Analysis of the cervical cancer distribution in Xinjiang. J Xinjiang Med Univ, 29, 569-71.
|
14 |
Tachezy M, Zander h, Gebauer F, et al (2013). CXCR7 expression in esophageal cancer. J Transl Med, 11, 238.
DOI
|
15 |
Wani N, Nasser MW, Ahirwar DK, et al (2014). C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment. Breast Cancer Res, 16, 54.
|
16 |
Wen WW, Xie S, Xin XL, et al (2013). Oligomannurarate sulfate inhibits CXCL12/SDF-1-mediated proliferation and invasion of human tumor cells in vitro. Acta Pharmacol Sin, 34, 1554-9.
DOI
|
17 |
Xue TC, Chen RX, Ren ZG, et al ( 2013). Transmembrane receptor CXCR7 increases the risk of extrahepatic metastasis of relatively well-differentiated hepatocellular carcinoma through upregulation of osteopontin. Oncol Rep, 30, 105-10.
|
18 |
Zabel BA, Lewen S, Berahovich RD, Jaen JC, Schall TJ (2011). The novel chemokine receptor CXCR7 regulates transendothelial migration of cancer cells. Mol Cancer, 10, 73.
DOI
|
19 |
Zhang GQ, Liu KJ, Lai XJ, et al (2003). The distribution of Malignant tumor in the Affiliated Tumor Hospital of Xinjiang Medical University from 1989 to 2002. J Xinjiang Med Univ, 26, 393-5.
|